{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:15:33Z","timestamp":1790630133989,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Haploinsufficiency of A20 (HA20) is an inflammatory disease caused by mutations in the <jats:italic>TNFAIP3<\/jats:italic> gene classically presenting with Behcet\u2019s-like disease. A20 acts as an inhibitor of inflammation through its effect on NF-kB pathway. Here we describe four consanguineous patients (three sisters and their mother) with a predominantly autoimmune phenotype, including thyroiditis, type I diabetes, hemolytic anemia and chronic polyarthritis. All patients had recurrent oral ulcers, with only 1 patient presenting also recurrent fever episodes, as a classical autoinflammatory feature. Next generation sequencing identified a novel heterozygous frameshift mutation (p.His577Alafs*95) that causes a premature stop codon in the zinc finger domain of A20, leading to a putative haploinsufficiency of the protein. Functional analyses confirmed the pathogenicity of the mutation. The variant was associated with decreased levels of A20 in blood cells. Accordingly, <jats:italic>ex-vivo<\/jats:italic> lipopolysaccharide (LPS)-stimulated patients\u2019 peripheral blood mononuclear cells (PBMCs) showed higher levels of p65 NF-kB phosphorylation, as well as increased production of the proinflammatory cytokines IL-1\u03b2, IL-6 and TNF-\u03b1. Moreover, in agreement with recent observations, demonstrating a role for A20 in inhibiting STAT1 and IFN\u03b3 pathways, markedly higher circulating levels of the two IFN\u03b3-inducible chemokines CXCL9 and CXCL10 were detected in all patients. Supporting the findings of a hyperactivation of IFN\u03b3 signaling pathway in HA20 patients, patients\u2019 monocytes showed higher levels of STAT1 without stimulation, as well as higher phosphorylated (active) STAT1 levels following IFN\u03b3 stimulation. In conclusion, our study show that in the clinical spectrum of HA20 autoimmune features may predominate over autoinflammatory features and demonstrate, from a molecular point of view, the involvement of A20 in modulating not only the NF-kB, but also the IFN\u03b3 pathway.<\/jats:p>","DOI":"10.3389\/fimmu.2022.804401","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T05:22:42Z","timestamp":1643174562000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of a Novel Mutation in TNFAIP3 in a Family With Poly-Autoimmunity"],"prefix":"10.3389","volume":"13","author":[{"given":"Marianna Nicoletta","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Uva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Passarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Celani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Caiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Petrocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Piano","family":"Mortari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"De Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Prencipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Insalaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-Of-Function Mutations in TNFAIP3 Leading to A20 Haploinsufficiency Cause an Early-Onset Autoinflammatory Disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3313","article-title":"A20: Linking a Complex Regulator of Ubiquitylation to Immunity and Human Disease","volume":"12","author":"Ma","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.574992","article-title":"Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00288-6","article-title":"Haploinsufficiency of A20 (HA20): Updates on the Genetics, Phenotype, Pathogenesis and Treatment","volume":"16","author":"Yu","year":"2020","journal-title":"World J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: The Human Genomic Variant Search Engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663329","article-title":"Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma","volume":"12","author":"Pascarella","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature02794","article-title":"De-Ubiquitination and Ubiquitin Ligase Domains of A20 Downregulate NF-kappaB Signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03bab Signaling in Inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.591966","article-title":"A20 Regulates Atherogenic Interferon (IFN)-\u03b3 Signaling in Vascular Cells by Modulating Basal Ifn\u03b2 Levels","volume":"289","author":"Moll","year":"2014","journal-title":"J Biol Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209454","article-title":"A20 Inhibition of STAT1 Expression in Myeloid Cells: A Novel Endogenous Regulatory Mechanism Preventing Development of Enthesitis","volume":"76","author":"De Wilde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00104","article-title":"A20\/Tumor Necrosis Factor \u03b1-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons From Mouse Models","volume":"9","author":"Das","year":"2018","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-306019","article-title":"B Cells Lacking the Tumor Suppressor TNFAIP3\/A20 Display Impaired Differentiation and Hyperactivation and Cause Inflammation and Autoimmunity in Aged Mice","volume":"117","author":"Chu","year":"2011","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629457","article-title":"Case Report: A Novel TNFAIP3 Mutation Causing Haploinsufficiency of A20 With a Lupus-Like Phenotype","volume":"12","author":"Shaheen","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00792-9","article-title":"Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3","volume":"40","author":"He","year":"2020","journal-title":"J Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.039","article-title":"Haploinsufficiency of A20 Causes Autoinflammatory and Autoimmune Disorders","volume":"141","author":"Kadowaki","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.02.012","article-title":"Autosomic Dominant Familial Beh\u00e7et Disease and Haploinsufficiency A20: A Review of the Literature","volume":"17","author":"Berteau","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.10.009","article-title":"Ubiquitin Binding to A20 ZnF4 is Required for Modulation of NF-kappaB Signaling","volume":"40","author":"Bosanac","year":"2010","journal-title":"Mol Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.09.015","article-title":"Direct, Noncatalytic Mechanism of IKK Inhibition by A20","volume":"44","author":"Skaug","year":"2011","journal-title":"Mol Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaci.2019.05.026","article-title":"Janus Kinase 1\/2 Inhibition for the Treatment of Autoinflammation Associated With Heterozygous TNFAIP3 Mutation","volume":"144","author":"Mulhern","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215918","article-title":"Type I Interferon Signature Predicts Response to JAK Inhibition in Haploinsufficiency of A20","volume":"79","author":"Schwartz","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.804401\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T05:22:43Z","timestamp":1643174563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.804401\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2022.804401"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.804401","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"article-number":"804401"}}